Patient Support Program KPIs: Enrollment, Activation, Retention and Safe Follow-up in Saudi Arabia

Patient Support Program KPIs: Enrollment, Activation, Retention and Safe Follow-up in Saudi Arabia

Measuring a patient support program in Saudi Arabia requires a different KPI framework than the engagement metrics borrowed from consumer apps or the clinical endpoints borrowed from registries. A Saudi PSP operates at the intersection of commercial objectives, pharmacovigilance obligations, and patient welfare — and each of those dimensions needs its own measurement layer.

This article defines the five KPI families used in well-governed Saudi PSPs, explains why the denominators matter as much as the numerators, and identifies the reporting errors that most commonly distort program performance pictures.

---

Key Takeaways

• Saudi PSP KPIs should cover five families: enrollment conversion, program activation, longitudinal retention, adverse event capture completeness, and sponsor reporting accuracy.
• The most common KPI error in Saudi PSPs is measuring activity (contacts made) instead of outcomes (contacts resulting in meaningful patient interaction).
• Denominators define what a KPI actually measures — reporting a 90% "adherence" rate without defining the denominator is not a KPI; it is an unqualified claim.
• Keywords are unvalidated editorial hypotheses (H); no search volume claims are made.

---

Why Saudi PSP KPIs Are Different

The measurement challenge in a Saudi PSP differs from both a clinical trial and a commercial loyalty program in ways that matter for how KPIs are defined.

Unlike a clinical trial, the PSP does not control patient selection, treatment protocol, or follow-up compliance. Patients enter on the recommendation of an HCP and are free to disengage at any time. The program's ability to retain and support patients is real but bounded — and KPIs that assume clinical-trial-level completeness will systematically mislead.

Unlike a consumer loyalty program, the PSP has pharmacovigilance obligations that create mandatory capture requirements. An engagement metric that ignores AE capture completeness is measuring the wrong thing — a program with high patient satisfaction scores and low AE capture rates is not a successful program; it is a compliance risk that has been mislabeled as success.

Saudi-specific factors add further complexity: patient-to-coordinator communications may be primarily in Arabic; family dynamics mean the enrolled patient may not be the primary decision-maker about program participation; and regional healthcare infrastructure variability means that "active follow-up" means different things in Riyadh than in a secondary care catchment.

---

KPI Family 1: Enrollment Conversion

Enrollment conversion measures the program's ability to translate HCP referrals into active program participants.

Primary metric: Enrollment rate = (patients who complete enrollment / patients referred by HCPs) × 100

Secondary metrics:

• Time-to-enrollment: days from HCP referral to completed patient registration
• Enrollment completion rate by step: proportion completing each stage of a multi-step enrollment process (useful for identifying drop-off points in digital enrollment flows)
• HCP participation rate: proportion of eligible HCPs who have referred at least one patient in a defined period

Common denominator errors: Enrollment rate calculated as (enrolled patients / total therapy starts in the market) is not a program enrollment rate — it is an uncontrolled market penetration estimate that blends program performance with HCP adoption, prescribing patterns, and competitive dynamics. The denominator for enrollment rate should be referred patients only.

Saudi context: Enrollment workflows in Saudi programs frequently require HCP verification and sometimes institutional registration with hospital pharmacy or medical affairs. Time-to-enrollment in hospital-based programs typically runs longer than in community pharmacy–based programs. KPIs should reflect the enrollment structure's inherent timeline, not an assumed consumer-app standard. [VERIFY WITH BRAND — specific enrollment timeline benchmarks require commercial validation]

---

KPI Family 2: Program Activation

Activation measures whether enrolled patients move from administrative registration to meaningful program engagement.

Primary metric: Activation rate = (patients completing first scheduled program interaction / patients who completed enrollment) × 100

Secondary metrics:

• Time-to-activation: days from enrollment completion to first program contact
• First interaction completion rate: proportion of first scheduled contacts that result in a completed meaningful exchange (not a voicemail, unanswered call, or incomplete digital session)
• Coordinator assignment completion: proportion of enrolled patients assigned to a named coordinator within the agreed SLA timeframe

Why activation differs from enrollment: An enrolled patient has entered their details and consented. An activated patient has actually engaged with the program's clinical support structure. These are not the same, and treating enrollment completion as a proxy for activation systematically overstates program reach.

Benchmark caution: Activation rates in Saudi PSPs vary significantly by therapy class, enrollment channel (hospital vs. community), and digital vs. phone delivery model. A "best in class" activation rate from a consumer health program is not an appropriate benchmark. [VERIFY WITH BRAND — specific activation benchmarks require program-type validation]

---

KPI Family 3: Longitudinal Retention

Retention measures the program's ability to sustain patient engagement over the therapy course.

Primary metric: Monthly retention rate = (patients with at least one meaningful contact in the month / patients enrolled and not discontinued) × 100

Secondary metrics:

• 90-day retention: proportion of patients enrolled in a cohort who remain active (at least one contact) at 90 days
• 180-day retention: same calculation at 180 days
• Lapse rate: proportion of patients with no contact for more than the program's defined lapse threshold (typically 60–90 days for a chronic therapy program)
• Reactivation rate: proportion of lapsed patients who re-engage after outreach

Defining "active": A patient is active only if they have had a meaningful interaction — a completed call with substantive clinical content, or a completed digital interaction including an AE prompt acknowledgment. A voicemail left, a push notification delivered, or a "seen" message is not an active patient interaction.

Denominator discipline: Retention calculations should exclude patients who have formally discontinued therapy or withdrawn program consent. Including these patients in the denominator inflates lapse rates and distorts the program's performance picture. The denominator for monthly retention should be (enrolled patients minus formally discontinued patients minus withdrawn consent patients) at the start of the reporting period.

---

KPI Family 4: Adverse Event Capture Completeness

AE capture completeness is the most consequential — and most underreported — KPI family in Saudi PSPs.

Primary metric: AE capture rate = (patient interactions that completed the structured AE prompt / total patient interactions completed) × 100

For programs with a mandatory AE prompt at every interaction, this should be close to 100%. A rate below 95% warrants investigation of workflow compliance. [HOLD — expert review: specific AE capture benchmarks require PV professional guidance]

Secondary metrics:

• Serious AE escalation timeliness: proportion of serious AEs transmitted to the sponsor safety contact within the SDEA-defined timeframe (typically 24 hours)
• AE minimum dataset completeness: proportion of captured AE reports with all four minimum valid dataset elements (identifiable reporter, identifiable patient, suspected product, suspected event)
• AE reconciliation timeliness: proportion of reconciliation cycles completed within the SDEA-defined schedule

Why this KPI family is frequently missing: Most Saudi PSP reporting dashboards show enrollment figures, contact volumes, and adherence estimates prominently. AE capture rates are rarely reported on the same dashboard — sometimes because the platform does not generate them, sometimes because the sponsor's reporting structure does not include pharmacovigilance metrics alongside commercial metrics. This is a governance gap, not a data gap. [HOLD — expert review: specific platform AE reporting requirements require PV professional validation]

---

KPI Family 5: Sponsor Reporting Accuracy

Reporting accuracy measures the degree to which data presented to the sponsor accurately represents the underlying program reality.

Primary metric: Data reconciliation discrepancy rate = (data elements that differ between platform-reported and sponsor-audited figures / total data elements audited) × 100

Secondary metrics:

• Report delivery timeliness: proportion of periodic reports delivered within the contractually defined schedule
• Definition consistency: whether reported metrics use the same denominators and definitions across reporting periods
• Audit trail completeness: proportion of reported patient interactions with accessible, immutable documentation in the platform

Why this matters: Sponsor reporting in Saudi PSPs frequently conflates activity metrics with outcome metrics, uses undefined denominators, or shifts definitions between reporting periods in ways that make trend analysis impossible. A program that shows consistently improving numbers by changing what the numbers measure is not improving — and a sponsor team that accepts this is not governing their program effectively.

---

Building a KPI Dashboard

A well-constructed Saudi PSP KPI dashboard presents three layers:

Program health (operational layer): Current enrollment, activation, and monthly retention rates — the indicators that signal whether the program is functioning as designed.

Safety compliance (pharmacovigilance layer): AE capture rate, serious AE escalation timeliness, and reconciliation status — the indicators required for inspection readiness.

Commercial performance (business layer): HCP participation rates, program reach relative to market, and trend data showing program maturation — the indicators used in brand-team and medical affairs reviews.

Each layer should report against defined targets established before the program launches, not against whatever the program has achieved to date. Post-hoc target-setting is not measurement; it is reclassification.

---

FAQ

What is a reasonable enrollment conversion rate for a Saudi PSP? Enrollment conversion rates vary significantly by therapy class, program design, and HCP engagement model. Rates above 50% from a referred-patient denominator are achievable in well-designed programs for specialty therapies with engaged HCPs; rates below 30% typically indicate either HCP engagement issues or enrollment friction that warrants investigation. These are directional observations, not benchmarks. [VERIFY WITH BRAND — specific enrollment benchmarks require commercial validation]

How should retention be measured for therapy programs with known seasonality or interruptions? Programs for therapies with predictable interruptions (seasonal conditions, treatment cycles) should define active periods explicitly and exclude scheduled non-active periods from lapse calculations. The retention denominator should reflect the population expected to be active in the measurement period.

Should we measure adherence or retention — and what is the difference? Adherence (a clinical endpoint describing whether a patient is taking their medicine as prescribed) and retention (a program operational endpoint describing whether the patient remains engaged with the support program) are different things, measured differently, with different denominators. PSPs measure retention; adherence, when estimated from pharmacy refill data or self-report, is a secondary clinical indicator that requires careful interpretation and expert review. [HOLD — expert review: clinical adherence measurement interpretation requires medical review]

What is the minimum AE capture rate that should be expected from a digital PSP? Any digital PSP that builds AE prompts into every patient interaction workflow should achieve near-universal AE prompt completion rates. Exceptions occur when patients drop out of an interaction before reaching the AE prompt step, which should itself be tracked as an interaction incompletion. [HOLD — expert review: specific AE capture minimums require PV professional guidance]

How often should KPI reports be reviewed with the program operator? Best practice is a monthly operational KPI review covering the program health layer, a quarterly review including the pharmacovigilance layer, and an annual review covering all five KPI families plus trend analysis and program design assessment. [VERIFY WITH BRAND — specific review cadences depend on program volume and contractual SLA requirements]

---

Published: 2026-11-05 · Author: CareSync Team · This article provides general guidance on KPI design for patient support programs in Saudi Arabia. It does not constitute legal, regulatory, or medical advice. KPI frameworks and pharmacovigilance metrics should be designed with qualified medical, regulatory, and operational advisors.

---

Review your PSP KPI framework with CareSync. Request a KPI design consultation →